ESC 365 - Efficacy and safety of edoxaban vs warfarin stratified by achieved blood pressure in 19,754 patients with hypertension in ENGAGE AF-TIMI 48

ESC Premium Access

Efficacy and safety of edoxaban vs warfarin stratified by achieved blood pressure in 19,754 patients with hypertension in ENGAGE AF-TIMI 48

Session: Hypertension and Atrial Fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor S. Park (Seoul, KR)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Sungha Park

Yonsei University, Seoul (Korea (Republic of))

1 presentation

0 follower

3 more presentations in this session

Fatal attraction: hypertension and atrial fibrillation - Current knowledge

Speaker: Professor A. Manolis (Athens, GR)

Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study

Speaker: Doctor E. Sharashova (Tromso, NO)

Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients

Speaker: Doctor T. Horio (Higashi-Osaka, JP)

Access the full session

Hypertension and Atrial Fibrillation

Speakers: Professor S. Park, Professor A. Manolis, Doctor E. Sharashova, Doctor T. Horio

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources